Sangamo Therapeutics Inc
NASDAQ:SGMO

Watchlist Manager
Sangamo Therapeutics Inc Logo
Sangamo Therapeutics Inc
NASDAQ:SGMO
Watchlist
Price: 2.47 USD 6.93% Market Closed
Market Cap: 515.4m USD
Have any thoughts about
Sangamo Therapeutics Inc?
Write Note

Wall Street
Price Targets

SGMO Price Targets Summary
Sangamo Therapeutics Inc

Wall Street analysts forecast SGMO stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for SGMO is 6.32 USD with a low forecast of 2.02 USD and a high forecast of 10.5 USD.

Lowest
Price Target
2.02 USD
18% Downside
Average
Price Target
6.32 USD
156% Upside
Highest
Price Target
10.5 USD
325% Upside
Sangamo Therapeutics Inc Competitors:
Price Targets
TLX
Telix Pharmaceuticals Ltd
8% Upside
QNCX
Quince Therapeutics Inc
416% Upside
SNDX
Syndax Pharmaceuticals Inc
185% Upside
PHM
Pharma Mar SA
3% Downside
ACHV
Achieve Life Sciences Inc
342% Upside
MNPR
Monopar Therapeutics Inc
8% Upside
NANO
Nanobiotix SA
328% Upside
GILD
Gilead Sciences Inc
8% Upside

Revenue
Forecast

Revenue Estimate
Sangamo Therapeutics Inc

For the last 8 years the compound annual growth rate for Sangamo Therapeutics Inc's revenue is 21%. The projected CAGR for the next 4 years is 0%.

21%
Past Growth
0%
Estimated Growth
Estimates Accuracy
0%
Average Miss

Operating Income
Forecast

Operating Income Estimate
Sangamo Therapeutics Inc

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-5%
Average Miss

Net Income
Forecast

Net Income Estimate
Sangamo Therapeutics Inc

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-56%
Average Miss

See Also

Discover More
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is SGMO's stock price target?
Price Target
6.32 USD

According to Wall Street analysts, the average 1-year price target for SGMO is 6.32 USD with a low forecast of 2.02 USD and a high forecast of 10.5 USD.

What is Sangamo Therapeutics Inc's Revenue forecast?
Projected CAGR
0%

For the last 8 years the compound annual growth rate for Sangamo Therapeutics Inc's revenue is 21%. The projected CAGR for the next 4 years is 0%.

Back to Top